These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38900228)

  • 1. Unifying gamma passing rates in patient-specific QA for VMAT lung cancer treatment based on data assimilation.
    Ono T; Adachi T; Hirashima H; Iramina H; Kishi N; Matsuo Y; Nakamura M; Mizowaki T
    Phys Eng Sci Med; 2024 Jun; ():. PubMed ID: 38900228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A robust approach to establish tolerance limits for the gamma passing rate-based patient-specific quality assurance using the heuristic control charts.
    Xiao Q; Bai L; Li G; Zhang X; Li Z; Duan L; Peng R; Zhong R; Wang Q; Wang X; Bai S
    Med Phys; 2022 Feb; 49(2):1312-1330. PubMed ID: 34778963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dose calculation algorithms on the helical diode array using volumetric-modulated arc therapy for small targets.
    Ono T; Hirashima H; Adachi T; Iramina H; Fujimoto T; Uto M; Nakamura M; Mizowaki T
    J Appl Clin Med Phys; 2024 Jul; 25(7):e14307. PubMed ID: 38363044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effect of high-density measurement mode on patient-specific quality assurance for head and neck cancer with ArcCHECK.
    Katayama H; Takahashi Y; Kobata T; Kawasaki H; Kitaoka M; Oishi A; Shibata T
    Phys Eng Sci Med; 2022 Dec; 45(4):1153-1161. PubMed ID: 36318385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans.
    Park JM; Kim JI; Park SY; Oh DH; Kim ST
    Radiat Oncol; 2018 Sep; 13(1):175. PubMed ID: 30217163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modulation factor and low dose threshold level on gamma pass rates of single isocenter multi-target SRT treatment plans.
    Timakova E; Zavgorodni SF
    J Appl Clin Med Phys; 2024 Jul; ():e14459. PubMed ID: 39053489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of prediction and classification performances in different machine learning models for patient-specific quality assurance of head-and-neck VMAT plans.
    Kusunoki T; Hatanaka S; Hariu M; Kusano Y; Yoshida D; Katoh H; Shimbo M; Takahashi T
    Med Phys; 2022 Jan; 49(1):727-741. PubMed ID: 34859445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it necessary to perform measurement-based patient-specific quality assurance for online adaptive radiotherapy with Elekta Unity MR-Linac?
    Xu Y; Xia W; Ren W; Ma M; Men K; Dai J
    J Appl Clin Med Phys; 2024 Feb; 25(2):e14175. PubMed ID: 37817407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-task autoencoder based classification-regression model for patient-specific VMAT QA.
    Wang L; Li J; Zhang S; Zhang X; Zhang Q; Chan MF; Yang R; Sui J
    Phys Med Biol; 2020 Nov; 65(23):235023. PubMed ID: 33245054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the Acuros XB spatial discretization error on ArcCHECK VMAT QA for small-field SBRT.
    He C; Pant A; Le AH
    J Appl Clin Med Phys; 2023 Sep; 24(9):e14100. PubMed ID: 37563870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a plan complexity mitigation algorithm based on gamma passing rate predictions for volumetric-modulated arc therapy.
    Ono T; Nakamura M; Ono Y; Nakamura K; Mizowaki T
    Med Phys; 2022 Mar; 49(3):1793-1802. PubMed ID: 35064567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient dose-volume histogram-based pretreatment patient-specific quality assurance methodology with combined deep learning and machine learning models for volumetric modulated arc radiotherapy.
    Gong C; Zhu K; Lin C; Han C; Lu Z; Chen Y; Yu C; Hou L; Zhou Y; Yi J; Ai Y; Xiang X; Xie C; Jin X
    Med Phys; 2022 Dec; 49(12):7779-7790. PubMed ID: 36190117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the planned, delivered dose distributions and quality assurance for helical tomotherapy and volumetric modulated arc therapy in locally advanced non-small cell lung cancer.
    Klunklin P; Manoharn T; Wanwilairat S; Nobnop W; Watcharawipha A; Chitapanarux I
    Rep Pract Oncol Radiother; 2021; 26(6):939-947. PubMed ID: 34992866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy.
    Han C; Zhang J; Yu B; Zheng H; Wu Y; Lin Z; Ning B; Yi J; Xie C; Jin X
    Radiat Oncol; 2023 Jul; 18(1):116. PubMed ID: 37434171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual pretreatment patient-specific quality assurance of volumetric modulated arc therapy using deep learning.
    Yoganathan SA; Ahmed S; Paloor S; Torfeh T; Aouadi S; Al-Hammadi N; Hammoud R
    Med Phys; 2023 Dec; 50(12):7891-7903. PubMed ID: 37379068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning for Patient-Specific Quality Assurance of VMAT: Prediction and Classification Accuracy.
    Li J; Wang L; Zhang X; Liu L; Li J; Chan MF; Sui J; Yang R
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):893-902. PubMed ID: 31377162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
    Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
    J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the gamma passing rates with the differences in the dose-volumetric parameters between the original VMAT plans and actual deliveries of the VMAT plans.
    Park JM; Choi CH; Wu HG; Kim JI
    PLoS One; 2020; 15(12):e0244690. PubMed ID: 33373394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment patient-specific quality assurance prediction based on 1D complexity metrics and 3D planning dose: classification, gamma passing rates, and DVH metrics.
    Chen L; Luo H; Li S; Tan X; Feng B; Yang X; Wang Y; Jin F
    Radiat Oncol; 2023 Nov; 18(1):192. PubMed ID: 37986008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbiased evaluation of predicted gamma passing rate by an event-mixing technique.
    Koganezawa AS; Matsuura T; Kawahara D; Nakashima T; Shiba E; Murakami Y; Nagata Y
    Med Phys; 2024 Jan; 51(1):5-17. PubMed ID: 38009570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.